Bioimpedance Control of Ultrafiltration on Hemodialysis

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: 1 R43 DK49892-01,
Agency Tracking Number: 29393
Amount: $100,000.00
Phase: Phase I
Program: SBIR
Awards Year: 1995
Solitcitation Year: N/A
Solitcitation Topic Code: N/A
Solitcitation Number: N/A
Small Business Information
Hemocleanse, Inc.
2701-B Kent Avenue, West Lafayette, IN, 47906
Duns: N/A
Hubzone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 Stephen Ash
 () -
Business Contact
Phone: () -
Research Institution
We will apply thoracic electric bioimpedance monitoring by external electrodes (TEB) to those patieunstable on hemodialysis and find a primary cardiovascular parameter which predicts the onset of symOur expectation is that percent fall in cardiac output will be the primary indicator, but we will alcardiovascular parameters, machine-generated ultrafiltration data, and SO2 and hematocrit (by Crit-Lthat there are no better predictors of symptomatic hypotension. We will define a "stop-UF" algorithmultrafiltration rate before symptomatic hypotension and clinically test this in Phase II. Also in Phclinically test a "dry weight" algorithm which monitors cardiovascular parameters and receives usersymptoms and clinical findings to automatically determine dry weight of all hemodialysis patients.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government